KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Assets: 2017-2024

Historic Current Assets for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $3.2 billion.

  • Elanco Animal Health's Current Assets rose 3.77% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 3.77%. This contributed to the annual value of $3.2 billion for FY2024, which is 5.64% down from last year.
  • Latest data reveals that Elanco Animal Health reported Current Assets of $3.2 billion as of FY2024, which was down 5.64% from $3.4 billion recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Current Assets registered a high of $3.4 billion during FY2020, and its lowest value of $3.2 billion during FY2024.
  • Over the past 3 years, Elanco Animal Health's median Current Assets value was $3.3 billion (recorded in 2022), while the average stood at $3.3 billion.
  • As far as peak fluctuations go, Elanco Animal Health's Current Assets spiked by 43.99% in 2020, and later decreased by 5.64% in 2024.
  • Elanco Animal Health's Current Assets (Yearly) stood at $3.4 billion in 2020, then fell by 4.18% to $3.3 billion in 2021, then grew by 0.15% to $3.3 billion in 2022, then rose by 3.90% to $3.4 billion in 2023, then dropped by 5.64% to $3.2 billion in 2024.